What caused MOVE.SW stock to drop today?

MOVE.SW stock fell on 04 Feb 2026 mainly due to profit taking and overbought technicals. RSI is **74.52** and MFI is **85.90**, prompting short-term selling. Elevated valuation versus peers likely accelerated the move.

What are the key support and resistance levels for MOVE.SW stock?

Immediate support is **CHF154.80** and the 50-day average resistance is **CHF159.45**. A break below support would test the 200-day average at **CHF146.98**.

What is Meyka AI's forecast for MOVE.SW stock?

Meyka AI's forecast model projects **CHF177.78** for the next month and **CHF223.19** for the year. These imply about **13.82%** and **42.90%** upside respectively from **CHF156.20**. Forecasts are projections, not guarantees.

How is MOVE.SW valued compared with the healthcare sector?

MOVE.SW trades at PE **36.24**, slightly above the sector average PE of **34.55**. PB is **8.10**, which is rich versus peers. Profitability metrics remain strong, but valuation is a headwind.

CH Stocks

MOVE.SW Medacta (SIX) intraday -6.58% to CHF156.20 04 Feb: watch CHF154.80

ByHuzaifa Zahoor February 4, 2026

The MOVE.SW stock slid 6.58% intraday to CHF156.20 on 04 Feb 2026 as profit taking hit after recent gains. Volume rose to 11,438 shares versus an average of 13,245. The intraday low was CHF154.80, which traders view as immediate support. This drop places Medacta Group S.A. (MOVE.SW) among the top losers on the SIX Switzerland session and sharpens focus on valuation and near-term catalysts.